The Slc26 gene family encodes several conserved anion transporters implicated in human genetic disorders, including Pendred syndrome, diastrophic dysplasia and congenital chloride diarrhea. We previously characterized the TAT1 (testis anion transporter 1; SLC26A8) protein specifically expressed in male germ cells and mature sperm and showed that in the mouse, deletion of Tat1 caused male sterility due to a lack of sperm motility, impaired sperm capacitation and structural defects of the flagella. Ca 21 , Cl 2 and HCO 3 2 influxes trigger sperm capacitation events required for oocyte fertilization; these events include the intracellular rise of cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA)-dependent protein phosphorylation. The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in mature sperm and has been shown to contribute to Cl 2 and HCO 3 2 movements during capacitation. Furthermore, several members of the SLC26 family have been described to form complexes with CFTR, resulting in the reciprocal regulation of their activities. We show here that TAT1 and CFTR physically interact and that in Xenopus laevis oocytes and in CHO-K1 cells, TAT1 expression strongly stimulates CFTR activity. Consistent with this, we show that Tat1 inactivation in mouse sperm results in deregulation of the intracellular cAMP content, preventing the activation of PKA-dependent downstream phosphorylation cascades essential for sperm activation. These various results suggest that TAT1 and CFTR may form a molecular complex involved in the regulation of Cl 2 and HCO 3 2 fluxes during sperm capacitation. In humans, mutations in CFTR and/or TAT1 may therefore be causes of asthenozoospermia and low fertilizing capacity of sperm.
INTRODUCTION
Sperm produced in the testis are non-motile and cannot fertilize the oocyte until they have undergone further maturation in the epididymis and in the female genital tract after ejaculation. The process of maturation in the epididymis renders the sperm motile, whereas that occurring during their transit in the female genital tract, known as capacitation, leads to the † Both authors contributed equally to this work. * To whom correspondence should be addressed at: Institut Cochin, INSERM, U1016, CNRS UMR 8104, Université Paris Descartes, Département Génétique et Développement, 24 rue du faubourg Saint-Jacques, 75014 Paris, France. Tel: +33 144412465; Fax: +33 144412468; Email: aminata. toure@inserm.fr hyperactivation of motility and enables the sperm to perform the acrosomal reaction prior to interaction with the oocyte.
Capacitation involves substantial changes affecting the biochemical, electrophysiological and functional properties of the sperm. Cholesterol depletion induces the reorganization of membrane phospholipids, and complex ion movements lead to hyperpolarization of the sperm plasma membrane potential, intracellular alkalinization and protein hyperphosphorylation.
Calcium (Ca 2+ ), chloride (Cl
2
) and bicarbonate (HCO 3
) ions are known to be indispensable for this process (1) . In particular, these three ions are responsible for increasing the intracellular cyclic adenosine monophosphate (cAMP) concentration and the subsequent activation of protein kinase A (PKA) and phosphorylation cascades essential for sperm capacitation (2) (3) (4) (5) . Ca 2+ and HCO 3 2 have been shown to bind directly to and activate the soluble adenylyl cyclase (sAC); however, it remains unclear whether participation of Cl 2 ions in this process also involves direct binding and activation of the sAC (5) .
Several ion channels and transporters are present in sperm, but their physiological substrates and their possible cooperation, cross-regulation and functional hierarchy remain unclear. The cystic fibrosis transmembrane conductance regulator (CFTR) conducts Cl 2 and HCO 3 2 anions and is defective in cystic fibrosis (CF). CFTR is expressed in the respiratory, digestive and genital epithelia and was recently shown to be expressed in mature sperm from mice, guinea pigs and humans where it contributes to Cl 2 and HCO 3 2 fluxes during sperm capacitation events (6) (7) (8) .
Hence Xu and coworkers have shown that CFTR is expressed at the equatorial segment of the sperm head in both mouse and human sperm. They also showed that the treatment of sperm with CFTR inh -172, a selective inhibitor of CFTR (9) , impaired the intracellular events associated with sperm capacitation, notably the increases in intracellular cAMP and pH and the membrane hyperpolarization, ultimately leading to lower levels of capacitation. Consistent with this finding, studies with a heterozygous mouse model of CF (CFTR tm1Unc ) showed the sperm from these mice to have a low fertilization capacity in vitro and in vivo, with impaired sperm motility and capacitation (6) .
Hernandez-Gonzalez et al. (7) concomitantly reported the expression of CFTR in mouse and human sperm but found it to be restricted to the midpiece of the flagella; they showed that it contributes to membrane potential hyperpolarization during capacitation by regulating the epithelial sodium channels (ENaC) in this structure.
Members of the solute carrier 26 (SLC26) family are anion exchangers that transport monovalent and/or divalent anions, including sulfate (SO 4 22 ), chloride (Cl ) and oxalate (Ox 22 ) ions (10) . Their activity is essential for various physiological functions and differentiation processes. Thus, 'loss-of-function' mutations in SLC26 genes cause a number of diseases in humans, including Pendred syndrome, deafness, diastrophic dysplasia and congenital chloride diarrhea (10, 11) . An important clue to the function of SLC26 transporters was provided by the discovery that several of these proteins form molecular complexes with the CFTR channel, resulting in the mutual regulation of their transport activity (12) (13) (14) (15) (16) (17) (18) (19) . SLC26A8/TAT1 (testis anion transporter 1) was initially cloned in our laboratory (20) as a member of the SLC26 family expressed exclusively in adult human testis. TAT1 expression in the testis was shown to be restricted to male germ cells at the spermatocyte and spermatid stages (20, 21) . The expression of TAT1 in COS-7 cells or Xenopus laevis oocytes facilitated the transport of SO 4 22 , Cl 2 and Ox 22 (20, 21) . However, the physiological substrates and functions of TAT1 in the germline remain to be demonstrated. We previously investigated TAT1 function by generating mice with a targeted disruption of the gene (22) . Tat1-null males were unable to sire offspring, although their mating behavior and reproductive organs were normal. Tat1-null sperm were entirely non-motile and displayed capacitation defects (lack of protein hyperphosphorylation and low frequency of acrosomal reaction). Tat1-null sperm also displayed severe structural defects, including hairpin-like bending of the flagella and structural defects of the annulus, a ring-shaped structure located at the junction of the midpiece and the principal piece of the flagella. Consistent with this phenotype, Tat1 protein was found at the annulus of mature sperm, in both humans and mice (22, 23) .
The recent observation of CFTR expression in sperm and its involvement in sperm capacitation prompted us to investigate the possible physical and functional interaction between CFTR and the sperm-specific member of the SLC26 family, TAT1. We also analyzed in more detail the sAC/PKA signaling pathway in sperm of Tat1-null mice.
We report that TAT1 physically interacts with the CFTR channel and that TAT1 expression strongly stimulates the activity of the CFTR channel. Consistent with these findings, we show that Tat1 inactivation in mouse sperm results in the deregulation of the intracellular cAMP content and a failure to trigger the sAC/PKA pathway. Thus, it is likely that, in sperm, TAT1 and CFTR cooperate in the regulation of the Cl 2 /HCO 3 2 fluxes required for motility and capacitation.
RESULTS

TAT1 and CFTR interact physically and functionally
We first investigated the physical interaction between TAT1 and the CFTR channel by co-immunoprecipitation experiments in COS-7 cells and CHO-K1 cells transiently transfected with plasmids encoding the TAT1 and CFTR full-length proteins. Unlike the control antibody directed against the transferrin receptor (TFR), the monoclonal M3A7 antibody directed against the CFTR channel specifically precipitated the TAT1 protein, indicating the existence of physical interactions between the two proteins (Fig. 1A) . To test whether, as previously described for other SLC26 members, the sulfate transporter and anti-sigma antagonist (STAS) domain was involved in the interaction with CFTR, we performed co-immunoprecipitation using a plasmid construct of the STAS domain (Myc-STAS construct). We observed that the M3A7 antibody specifically co-precipitates CFTR and the Myc-STAS fusion protein (Fig. 1B) . To confirm the above results, we performed coimmunoprecipitation experiments in testis protein extracts from the Flag-Tat1 +/+ transgenic mice and from the Tat1-null In protein extract from the Flag-Tat1 +/+ transgenic mice, significant co-precipitation of the CFTR protein was obtained when compared with that of Tat1-null mice, indicating that TAT1 and CFTR are likely to interact in vivo (Fig. 1C) .
We next tested for functional effects of TAT1 expression on CFTR activity by performing voltage-clamp experiments in X. laevis oocytes producing CFTR and TAT1 alone or in combination. Current -voltage relationships (I -V curves) were established in control condition (superfusion of the oocytes with ND96) or during PKA stimulation [superfusion of the oocytes with the stimulating mixture Fsk/3-isobutyl-1-methylxanthine (IBMX)] in the presence or absence of the CFTR inhibitor (CFTR inh -172). We observed that I-V curves from oocytes expressing TAT1 alone were not affected by PKA stimulation or CFTR inh -172 treatment ( Fig. 2A) .
In control condition, oocytes expressing CFTR alone or co-expressing both TAT1 and CFTR exhibited I-V curves that were indistinguishable (Fig. 2B) . In contrast, in these oocytes, PKA stimulation resulted in a large increase in whole-cell conductance (Fig. 2B ). This increase was sensitive to CFTR inh -172, indicating that it was related to CFTR activation (Fig. 2B) . Interestingly, in oocytes co-expressing TAT1 and CFTR, PKA-stimulated currents were significantly larger than those in oocytes expressing CFTR alone (Fig. 2B) . Current amplitudes from these experiments, measured at 2100/+40 mV, are shown in Figure 2C . Taken together, these findings strongly suggest that TAT1 expression had a stimulatory effect on CFTR-mediated currents in X. laevis oocytes.
We confirmed the stimulatory effect of TAT1 on the cAMP-dependent CFTR channel by performing iodide efflux experiments in CHO-K1 cells stably expressing CFTR and transiently transfected with TAT1 constructs. Iodide efflux was recorded for 10 min and CFTR was stimulated by addition of forskolin (Fsk) after 3 min. Curves were constructed by plotting the rate of 125 I efflux against time ( Fig. 3A and C) ; histograms, which are used for comparisons, indicate the maximal value to the time-dependent rates ( Fig. 3B and D) .
Using cells not transfected and cells transfected with the empty plasmid as controls, we found that TAT1 expression enhanced the iodide efflux mediated by the CFTR channel ( Fig. 3A and B) . We also tested SLC26A3 (DRA) construct and observed, as previously described (12) , a stimulatory effect on CFTR activity ( Fig. 3A and B) . Interestingly, a truncated construct of TAT1 lacking the STAS domain (TAT1 DSTAS), although expressed at a similar level as wild-type TAT1 (Supplementary Material, Fig. S1A ), did not stimulate CFTR activity in this way (Fig. 3B) .
A set of control experiments was performed in CHO-K1 cells, which do not overexpress the human CFTR channel; as reported in previous studies on TAT1, TAT1 expression alone was unable to mediate any iodide efflux (20) and Fsk addition had no effect ( Fig. 3C and D) .
The total amount of CFTR and the amount presumably addressed to the plasma membrane (glycosylated and mature form), as assessed by western blotting, were not increased by the presence of TAT1 (Supplementary Material, Fig. S1 ). The total amount of CFTR was not either diminished by the co-expression of the DSTAS version of TAT1 (Supplementary Material, Fig. S1 ). Therefore, we conclude that TAT1 directly stimulates CFTR conductance and requires the STAS domain to do so.
TAT1 and CFTR are co-localized in sperm
Using an antibody directed against the carboxy-terminal region (amino acids 664-970) of the human TAT1 protein, we previously showed that TAT1 protein co-localizes with members of the Septin family (Septin 1, 4, 6, 7 and 12) at the annulus of human and mouse sperm (22, 24, 25) . We recently generated a new antibody directed against both amino-and carboxy-terminal peptides of the human TAT1 protein (amino acids 1 -15 and 955-970), the specificity of which was confirmed based on (i) the correct immunodetection of the TAT1 protein on COS cells transiently transfected with a TAT1 expression plasmid and (ii) the similarity of the profiles obtained with both antibodies (data not shown). Using this antibody for immunofluorescence-based localization, we found that the TAT1 protein was present at both the annulus and the equatorial segment of the human sperm head (Fig. 4A ). As expected from the divergence between mouse and human TAT1 protein sequences, this antibody did not react with the mouse Tat1 protein, precluding its use for the study of Tat1 in the mouse.
The experimental conditions for TAT1 and CFTR detection were different, so double labeling experiments were not feasible. However, in our investigations of the potential co-localization of TAT1 and CFTR in the flagella, we used the CF3 mouse monoclonal antibody against CFTR to determine the precise distribution of this protein in sperm preparations. We detected CFTR in both the equatorial segment of the head and the midpiece of mouse sperm. This finding reconciles the apparently conflicting reports of Xu et al. and Hernandez-Gonzalez et al., who reported CFTR expression in the head and midpiece, respectively (Fig. 4B) . Interestingly, in about half of the sperm, we also observed a mass of CFTR protein close to the end of the midpiece (Fig. 4A ). Double staining for Septin 4, a structural component of the annulus, revealed that CFTR did not precisely co-localize with the annulus but was rather located at the proximal border of the annulus (Fig. 4B ).
Tat1-null sperm display abnormal cAMP content
Ca 2+ , Cl 2 and HCO 3 2 are known to induce cAMP production, a key event in the initiation of capacitation, leading to downstream PKA-dependent protein phosphorylation cascades. Tat1-null mouse sperm displays a lack of motility (asthenozoospermia) and capacitation defects, as shown by the absence of protein hyperphosphorylation and a low acrosomal reaction capacity (22) . We analyzed the cAMP content of wild-type and Tat1-null sperm in basal conditions (NO medium) and in capacitating conditions (CAP). The basal cAMP content was higher in Tat1-null sperm than in wild-type sperm and the increase in the cAMP concentration induced during sperm capacitation was smaller in Tat1 2/2 than in wild-type sperm (Fig. 5A) . Altogether, the cAMP Figure 2 . Current-voltage (I-V) relationships in X. laevis oocytes expressing human TAT1 and CFTR alone or both. Results from a representative two-electrode voltage-clamp experiment performed with X. laevis oocytes expressing TAT1 (n ¼ 7) or CFTR alone (n ¼ 7), or co-expressing TAT1 and CFTR (n ¼ 11). Similar results were obtained in three independent experiments. (A) I-V curves from oocytes expressing TAT1 alone in control conditions (superfused with ND96, black line) or in the presence of a PKA-stimulating mixture (1 mM Fsk and 100 mM isobutylmethylxanthine, Fsk + IBMX) supplemented (red line) or not (green line) with 10 mM of the CFTR inhibitor, CFTR inh -172. These treatments had no effect on whole-cell currents in TAT1-expressing oocytes, such that the three I-V curves overlap. (B) I-V curves from oocytes expressing CFTR alone (open circles) or co-expressing CFTR and TAT1 (filled circles), in control conditions (superfused with ND96, black line) or in the presence of the PKA-stimulating mixture supplemented (red line) or not (green line) with 10 mM of the CFTR inhibitor, CFTR inh -172. I-V curves obtained from oocytes expressing CFTR alone or co-expressing CFTR and TAT1 are indistinguishable before PKA stimulation. Of note, PKA stimulation induced a larger increase in cell conductance in oocytes co-expressing CFTR and TAT1 than in oocytes expressing CFTR alone; this increase was sensitive to CFTR inh -172, indicating that it was related to CFTR activation. (C) Results from the same experiment presented as histograms of whole-cell currents measured at 2100 and +40 mV values (Student's t-test, * P , 0.05).
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Human Molecular Genetics, 2012, Vol. 21, No. 6 concentration upon capacitation was clearly lower in Tat1-null than in control sperm (Fig. 5B) . We next analyzed the expression and distribution of the soluble adenylate cyclase (sAC) in wild-type and Tat1-null sperm retrieved from the caudal region of the epididymis and capacitated in vitro. As previously described, sAC was found at the annulus in capacitated sperm (Fig. 6A) . Furthermore, despite the bending of the flagella, sAC was correctly located at the annulus of Tat1-null sperm upon capacitation (Fig. 6B ). This indicates that the motility and capacitation defects in Tat1-null sperm do not result from misproduction or mislocalization of the sAC but rather from its misactivation.
cAMP analogs restore hyperphosphorylation and flagellar beating in a PKA-dependent manner in Tat1-null sperm
We incubated wild-type and Tat1-null sperm in a medium not permissive to capacitation but supplemented with dibutyrylcAMP and analyzed the tyrosine phosphorylation pattern associated with sperm capacitation, by western blot analysis. We observed partial restoration of the tyrosine phosphorylation pattern associated with sperm capacitation in Tat1-null sperm (Fig. 7A) . Incubation with Sp-cAMP, another active permeant analog of cAMP, gave similar results; furthermore, control experiments involving co-incubation of Tat1-null sperm with both Sp-cAMP and Rp-cAMP, a specific competitive inhibitor of cAMP, prevented hyperphosphorylation rescue (data not shown). The re-establishment of hyperphosphorylation in Tat1-null sperm was also prevented by incubation with H89, a specific inhibitor of PKA activity, before the addition of dibutyryl-cAMP to the medium (Fig. 7B) .
Finally, we used videomicroscopy to analyze the behavior of Tat1-null sperm in the presence of dibutyryl-cAMP. Unlike untreated sperm and sperm treated with IBMX alone, sperm treated with dibutyryl-cAMP and IBMX displayed flagellar beating, although they did not fully recover their swimming capacity (Supplementary Material, Movies).
DISCUSSION
Sperm must undergo an activation process, called capacitation, during their transit in the female genital tract if they are to acquire their fertilization potential. This activation process involves multiple modifications to the sperm, including * * * P , 0.001; * * P , 0.01; * P , 0.05; ns, not significant. plasma membrane phospholipid reorganization, an increase in intracellular cAMP concentration and protein phosphorylation, intracellular alkalinization and plasma membrane potential hyperpolarization. Sperm capacitation is partly triggered by complex anion movements including Cl 2 and HCO 3 2 influxes. CFTR has recently been implicated in this process, so we investigated the role of TAT1, which, as a member of the SLC26 anion transporter family specifically expressed in the male germ line, appears as a candidate regulator of CFTR function in sperm. We found that (1) TAT1 and CFTR form a molecular complex and that upon PKA stimulation, TAT1 expression enhances CFTR-mediated currents in X. laevis oocytes and iodide transport in CHO-K1 cells; (2) CFTR was present in both the equatorial segment and the midpiece of the flagellum, where it was found close to the annulus; (3) TAT1 was also present in the equatorial segment of the sperm in addition to the annulus; (4) despite correct production and localization of sAC to the annulus, Tat1-null sperm displayed only a minor increase in cAMP concentration upon capacitation and were unable to trigger the sAC/PKA signaling pathway leading to protein phosphorylation. Consistent with these findings, we finally showed that membrane-permeant analogs of cAMP restored, in a PKA-dependent manner, protein hyperphosphorylation and flagellar beating in Tat1-null sperm.
Our results are consistent with the notion that like other SLC26 anion exchangers, TAT1 interacts with and stimulates the activity of CFTR. It is therefore possible that TAT1 and CFTR form a complex in vivo involved in the regulation of the Cl 2 and HCO 3 2 fluxes required for activation of the sAC/PKA pathway during sperm capacitation. (8) recently described the expression of SLC26A3 in the guinea pig sperm head and suggested a functional interaction, although they did not find precise co-localization of CFTR and SLC26A3 proteins in the sperm head (CFTR being found at the equatorial segment and SLC26A3 in the acrosome).
We show here that in addition to its localization at the annulus initially detected with the L2Cl4 antibody, TAT1 (SLC26A8) is also detected at the equatorial segment when using a novel antibody directed against both amino-and carboxy-peptides of the TAT1 protein. As both antibodies have been shown to be specific for TAT1, the accessibility of the epitopes could explain this difference. Taken together, these results indicate that TAT1 co-localizes with CFTR in sperm head and locates in close proximity to CFTR in the flagella. TAT1 has been reported to carry sulfate, chloride and oxalate anions (20, 21) but no HCO 3 2 transport activity has been detected (our unpublished data); the mechanism of TAT1-mediated ionic transport remains to be determined. We found that functional expression of TAT1 in X. laevis oocytes did not significantly affect whole-cell conductance. Therefore, as reported for other SLC26 members, TAT1 may act as an electroneutral anion exchanger. Importantly, we demonstrate in this study that like several other SLC26 members, TAT1 interacts physically with CFTR and stimulates its activity via the STAS domain. In addition to the primary role of the STAS domain for the interaction of SLC26 transporters with the R domain of CFTR, the contribution of a carboxy-terminal PDZ binding motif has been documented, in particular, for SLC26A3/CFTR interaction. In the Figure 6 . Detection of the sAC in wild-type and Tat1 2/2 capacitated sperm. Distribution of the sAC was analyzed by immunodetection in sperm isolated from Tat1 +/+ (A) and Tat1 2/2 (B) epididymis and capacitated in vitro for 90 min at 378C. Images were taken with a 100× objective; Left panels: merged color images; sAC (red) and DAPI (blue). Right panels: merged color images; sAC (red) and phase-contrast images (grey). (26) is also present at the carboxy terminus of human TAT1 protein and could be implicated. Altogether, the available data are consistent with SLC26A3 and TAT1 (SLC26A8), both contributing to anion flux regulation in sperm; this may involve their intrinsic anion transport activity and/or their capacity to stimulate the anion transport activity of CFTR. Consistent with a potentially important role for TAT1 in sperm capacitation and as reported for Cftr +/2 sperm by Xu et al. (6), we show that the increase in the intracellular cAMP concentration in Tat1-null sperm is significantly impaired. However, sAC is correctly localized at the annulus of Tat1-null sperm, suggesting that the lack of motility and the capacitation defects result from their inability to trigger the PKA signaling pathway.
Surprisingly, in basal conditions, Tat1-null sperm had higher cAMP contents than wild-type sperm. We have no information about the basal levels of cAMP in Cftr +/2 sperm, but Nolan et al. (27) reported that basal levels of cAMP were high in Ca 2 PKA-null sperm. Furthermore, Hess et al. (28) observed that sAC-null sperm had abnormal hyperphosphorylation patterns in conditions that were not permissive for capacitation. These various observations strongly suggest the existence of negative feedback mechanisms regulating cAMP production, involving either stimulation of phosphodiesterase activity or inhibition of sAC activity.
The location of sAC and TAT1 at the annulus, in close proximity to CFTR, suggests the existence of a spatially confined Cl 2 /HCO 3 2 -dependent pathway resulting in local cAMP production close to the annulus. The reason for any such local cAMP production is unclear and, indeed, direct (PKA) and indirect targets of cAMP are found along the length of the flagella. Nevertheless, these findings are consistent with the hypothesis of a functional interaction between TAT1 and CFTR in vivo, with both proteins being required for sAC/ PKA activation.
We also show that TAT1 and CFTR strictly co-localize at the equatorial segment of the sperm head, suggesting that interaction between both proteins could be involved in capacitation events required for the acrosomal reaction. Consistent with this, we have previously described a significant reduction of the acrosomal reaction in Tat1-null sperm (22); furthermore, inhibition of CFTR in human and mouse sperm was shown to impair the acrosomal reaction (6,7).
These results are collectively potentially valuable for improving our understanding of the genetic etiological factors responsible for human infertility. CFTR mutations cause CF, a genetic disease affecting the homeostasis of Cl 2 and HCO 3 2 in epithelial cells in the airways, intestine and genital tract (29) . In addition to displaying respiratory and digestive symptoms, both men and women with CF display impaired fertility (30) ; .95% of male CF patients are infertile due to a congenital bilateral absence of vas deferens (CBAVD) (31) and many women with CF are subfertile due to a viscous mucus in the cervix that may create a barrier to sperm passage, and/or to defective bicarbonate secretion in the genital tract, preventing successful sperm capacitation (32, 33) .
Several studies have reported a significantly higher frequency of heterozygous CFTR mutations in infertile male populations without CBAVD and with infertility of unknown origin (34, 35) . This observation raises the possibility of CFTR being involved in other (non-CBVAD) sperm disorders. By regulating the ion exchanges required for sperm capacitation, CFTR and TAT1 are clear candidate genes for infertility, and mutations in these genes may be involved in human cases of asthenozoospermia and/or an inability of sperm to fertilize oocytes.
In conclusion, we describe here a new model of the physical and functional interactions between CFTR and members of the SLC26 family. This is of particular interest to sperm physiology and pathophysiology and may also be useful to improve our understanding of the molecular basis of CFTR function and dysfunction.
MATERIALS AND METHODS
All experiments with human and animal samples were conducted in accordance with the ethical guidelines and were approved by the Ethics Evaluation Committee (CQI) of the Institut National de la Santé et de la Recherche Médicale, INSERM (Authorization No. 01-013).
Co-immunoprecipitation and immunoblotting
COS-7 cells cultured in 10 cM plates were transiently transfected, according to the standard FuGENE (Roche) protocol, with 5 mg of the following plasmids in a 1:1 ratio: pRK5-TAT1 and green fluorescent protein (GFP)-tagged CFTR or empty vector. CHO-K1 cells cultured in 10 cM plates were transiently transfected, according to the standard JetPEI (Polyplus Transfection) protocol, with 10 mg of the following plasmids in a 1:1 ratio: pRK5-Myc-STAS and GFP-tagged CFTR or empty vector.
After 24 h, cells were washed twice in cold phosphatebuffered saline (PBS) and lysed in 500 ml of lysis buffer (50 mM Tris -HCl, pH 8, 150 mM NaCl, 10 mM MgCl 2 , 0.5% NP40, 1× Complete protease inhibitor cocktail (Roche)) for 30 min at 48C. Cellular residues were eliminated by centrifugation at 13 000g, 48C, for 20 min. We removed 50 ml of supernatant, of which 30 mg of proteins was used to check transfection efficiency. Then, 2 mg of anti-CFTR antibody (M3A7 mouse monoclonal antibody) or 2 mg of anti-TFR was added to the remaining 450 ml of supernatant and the mixture incubated at 48C overnight.
We added 40 ml of Protein G agarose beads (previously washed three times in cold 1× PBS) to each sample, which was then incubated for 2 h at 48C, with shaking. The beads were then washed twice in washing buffer (50 mM TrisHCl, pH 8, 150 mM NaCl, 10 mM MgCl 2 , 0.1% NP40, 1× Complete protease inhibitor cocktail (Roche)), and proteins were eluted in 30 ml of 2× sample buffer. Samples were incubated for 5 min at 958C to denature proteins and centrifuged for 5 min at 13 000g and 48C. The supernatant was subjected to sodium dedecyl sulfate -polyacrylamide gel electrophoresis (SDS -PAGE), and the resulting bands were transferred to nitrocellulose for immunoblotting (mouse monoclonal M3A7 antibody, rabbit polyclonal L2CL4-TAT1 antibody, mouse anti-TFR).
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The Flag-Tat1 +/+ transgenic mice were obtained by targeted insertion of a cDNA construct comprising of Tat1 mouse partial open reading frame fused to the Flag epitope, into the Tat1 locus. Tat1-null mice were previously described (22) . Testis from Flag-Tat1 +/+ transgenic mice and Tat1-null mice were dissected and proteins were extracted in lysis buffer: 50 mM Tris -HCl, pH 8, 150 mM NaCl, 10 mM MgCl 2 , 0.5% NP40, 1× protease inhibitor cocktail (following a ratio of 10 ml of lysis buffer per milligram of testis). Immunoprecipitation was performed with 1 mg of proteins incubated with 8.4 mg of mouse monoclonal M2 antibody (Sigma-Aldrich, Lyon, France). In this case, 50 ml of supernatant was removed, of which 50 mg of proteins was used to check the transfection efficiency.
Heterologous expression of TAT1 and CFTR in X. laevis oocytes Human cDNA sequences coding for TAT1 and CFTR were inserted into pGH19 (kindly provided by Dr W.F. Boron, Case Western University, Cleveland, OH, USA) and pT7TS plasmids, respectively. The pGH19-TAT1 and pT7TS-CFTR constructs were linearized with appropriate restriction enzymes (NotI and SmaI, respectively; New England BioLabs), and cRNAs were transcribed in vitro using mMES-SAGE MACHINE w (Ambion). Defolliculation of oocytes (obtained from the partial ovariectomy of female X. laevis) was achieved by gentle shaking (2 h, at room temperature) in calcium-free ND96 (composition of ND96 in mmol/l: NaCl, 96; KCl, 2; MgCl 2 , 1; CaCl 2 , 1 buffered to pH 7.5 with 5 HEPES/NaOH) supplemented with 2 U/ml type 1A collagenase (Sigma-Aldrich); stage V-VI oocytes were injected (Inject + Matic microinjector, Geneva, Switzerland) with 1 ng of cRNA coding for CFTR and/or 20 ng of cRNA coding for TAT1 dissolved in RNAsefree water (50 nl) or with water alone (control oocytes). The oocytes were incubated at 188C in ND96 supplemented with penicillin (100 U/ml)/streptomycin (100 mg/ml) for 3 -4 days and then used for experiments. Heterologous protein expression was studied by western blot analysis of total and membrane proteins, as described elsewhere (36) .
Electrophysiological measurements
Two-electrode voltage clamp experiments were performed with oocytes expressing either TAT1 or CFTR or both. The oocytes were placed in a microchamber and punctured with two low-resistance (0.5 -3 MV), 3 M KCl-filled microelectrodes. The microelectrodes and a virtual ground amplifier (VG2-A 100, Axon Instruments, Union City, CA, USA) were connected to a current -voltage amplifier (Axoclamp 2B, Union City, CA, USA); the electrical circuit was closed with two bath electrodes (an agar-3 M KCl bridge electrode and an Ag -AgCl pellet) to minimize serial resistance-induced errors (37) . The oocytes were superfused with ND96 or with test solution: a stimulating mixture (1 mM Fsk and 100 mM isobutylmethylxanthine IBMX) was added to ND96 to stimulate PKA; 10 mM of CFTR inh -172 (Calbiochem) was added to ND96 to inhibit CFTR (9).
Current -voltage (I-V) relationships were obtained by applying voltage steps of +20 mV (range -100 to +50 mV, 5 s duration) from the resting membrane potential value using the Clampex9-generated protocol (Axon Instruments). Results were analyzed using P-Clamp9 software program (Axon Instruments).
Iodide efflux assays
CHO-K1 cells stably expressing human CFTR or CHO-K1 cells were transiently transfected with the following plasmid constructs: pRK5, pRK5-TAT1 wt, pRK5-TAT1 DSTAS and pCMV-SLC26A3 (DRA) wt for 48 h. The CFTR Cl 2 channel activity was assayed by measuring the rate of iodide ( 125 I) efflux from the cells as described previously (38 ).
Human sperm smear preparation
Semen samples were obtained from normal fertile volunteers by masturbation, after a period of 2 -5 days of abstinence; samples were then incubated at 378C for 30 min, for liquefaction. Sperm viability, morphology and motility were checked by eosin staining, Giemsa staining and CASA analysis, respectively.
We spread 20 ml of liquefied sperm onto Superfrost Plus slides (Menzel Glasbearbeitungswerk, GmbH & Co. KG, Braunschweig, Germany). The sperm was allowed to dry briefly and fixed by incubation for 10 min in cold methanol/acetone (3:1). Slides were stored at 2808C until immunodetection.
Mouse sperm smear preparation
The caudal regions of the mouse epididymis were dissected in 1 ml of preheated (378C) NO medium (120 mM NaCl, 2 mM KCl, 1.2 mM MgSO 4 , 0.36 mM NaH 2 PO 4 , 5.56 mM glucose, 1 mM sodium pyruvate, 18.5 mM sucrose, 50 mM HEPES, pH 7.3) and incubated at 378C for 15 min. Paraformaldehyde was then added to a final concentration of 3.6% and the sperm was fixed by incubation for 30 min at room temperature. We spread 20 ml of fixed sperm onto Superfrost Plus slides (Menzel Glasbearbeitungswerk, GmbH & Co. KG) and allowed it to dry briefly. Slides were stored at 2808C until immunodetection.
Immunodetection in sperm preparations
The fixed slides were treated with 0.2% Triton in PBS for permeabilization and were then blocked by incubation in 1% bovine serum albumin (BSA; for human sperm analysis) or 10% normal goat serum (for mouse sperm analysis) in PBS for 1 h. Slides were then incubated with primary antibodies for 2 h at room temperature (TAT1 and sAC antibodies) or Slides were analyzed with a Zeiss Axiophot epifluorescence microscope. Digital images were acquired with a cooled charge-coupled device camera (Hamamatsu Co., Japan), under identical instrument settings, with MetaMorph w software (Molecular Devices, Inc., USA). Several Z acquisitions were performed for TAT1 detection at both the annulus and the equatorial segment; Z projections were then performed with Image J 1.44c
w software (National Institute of Health, USA).
Measurement of cyclic AMP content
We collected Tat1 +/+ and Tat1 2/2 sperm by dissecting the caudal region of the epididymis in 1 ml of a medium not supporting capacitation (NO medium). After a short incubation at 378C, the sperm were collected and counted. We incubated 0.5-1.5 × 10 6 sperm for 10 min in a medium not supporting (NO) or supporting (CAP) capacitation, supplemented with 100 mM IBMX, in a final volume of 400 ml.
After incubation, the sperm were centrifuged at 13 000g for 10 min at room temperature and resuspended at a concentration of 1 × 10 6 sperm/100 ml in 0.1 M HCl , 1% Triton X-100. The sperm suspension was centrifuged at 13 000g for 10 min at room temperature and 100 ml of the resulting supernatant was assayed for cAMP concentration according to the kit manufacturer's protocol (Direct Cyclic AMP Enzyme Immunoassay Kit Assay Designs).
Hyperphosphorylation assay
We collected Tat1 +/+ and Tat1 2/2 sperm by dissecting the caudal region of the epididymis in 1 ml of NO medium, followed by a short period of incubation at 378C. Sperm was counted and diluted to 2 × 10 6 sperm in 400 ml of the appropriate medium: medium not supporting capacitation (NO), capacitation medium (CAP) or NO medium supplemented with 1 mM db-cAMP and 100 mM IBMX. The sperm were incubated in the media for 90 min at 378C, under an atmosphere containing 5% CO 2 .
For H89 inhibition assays, 2 × 10 6 spermatozoa were incubated in 200 ml of NO medium. H89 [diluted in dimethyl sulfoxide (DMSO)] was added to a final concentration of 200 mM and sperm were incubated for 10 min at 378C, under an atmosphere containing 5% CO 2 . The medium was then supplemented with 200 ml of capacitation medium (CAP) or a medium not supporting capacitation with 1 mM db-cAMP and 100 mM IBMX and for the resulting sperm suspension was incubated for 50 min at 378C under an atmosphere containing 5% CO 2 .
After incubation, the sperm were washed once with 1 mM Na 3 VO 4 -5 mM PPi in PBS and proteins were extracted by adding Laemmli buffer (4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004% bromophenol blue, 0.125 M Tris-HCl). These protein extracts were subjected to SDS-PAGE (1 × 10 6 cells/lane) and transferred to a nitrocellulose membrane for immunoblotting with antibodies against phosphorylated tyrosine (4G10 mouse monoclonal antibody; Upstate).
Plasmid constructions
The pRK5-Myc-STAS construct comprises the entire STAS domain corresponding to amino acids 543-795 of the TAT1 protein. pRK5-Myc-STAS construct was generated by PCR using the primer pair STASBamFw: 5 ′ -GCAGAGGGATC CGATTATCGGGAGATCATC and STASHindRv: 5 ′ -TAT ATAAAGCTTCTAGGCAAACAGCACGGCGTC, followed by BamHI and HindIII digestion and subcloning into the pRK5-Myc plasmid.
The STAS-truncated TAT1 construct was generated by engineering NheI sites flanking the STAS domain of TAT1 (between 1626 and 1627 bp and between 2385 and 2386 bp of the cDNA sequence). The STAS region (1627-2385 bp, '. . . DYREII . . . DAVLFA . . .') was next removed by restriction digest with NheI and subjected to agarose gel purification. The resulting fragment was then religated and resulted in the STAS-truncated form, pRK5-TAT1 DSTAS.
pCMV-SLC26A3 (pCMVhDRA) construct is a gift from Shmuel Muallem (University of Texas, Dallas, TX, USA) and pT7TS-CFTR is a gift from Cherif-Zahar (INSERM U845, Paris, France).
Media
Medium not supporting capacitation (NO): 120 mM NaCl, 2 mM KCl, 1.2 mM MgSO 4 , 0.36 mM NaH 2 PO 4 , 5.56 mM glucose, 1 mM sodium pyruvate, 18.5 mM sucrose, 50 mM HEPES, pH 7.3. Capacitation medium (CAP): 120 mM NaCl, 2 mM KCl, 1.2 mM MgSO 4 , 0.36 mM NaH 2 PO 4 , 5.56 mM glucose, 1 mM sodium pyruvate, 18.5 mM sucrose, 50 mM HEPES, 1.8 mM CaCl 2 , 25 mM NaHCO 3 , 3% BSA, pH 7.3. COS-7 cell medium (Dulbecco's modified Eagle medium) and CHO-K1 cell medium (minimum essential medium) were purchased from Gibco.
Chemicals and antibodies
db-cAMP, IBMX, H89, Na 3 VO 4 and PPi were purchased from Sigma-Aldrich. Sp-cAMP and Rp-cAMP were purchased from BioLog (Bremen, Germany). FuGENE transfection reagent and Complete Protease Inhibitor Cocktail were obtained from Roche Applied Science (Meylan, France). JetPEI transfection reagent was purchased from Polyplus Transfection.
Fsk was purchased from LC Laboratories (PKC Pharmaceuticals, USA). The CFTR inhibitor CFTR inh -172 (3-[(3-trifluoromethyl)-phenyl]-5-[(4-carboxyphenyl)methylene]-2-thioxo-4-thiazolidinone) was from VWR International (Fontenay-sous-Bois, France).
The anti-TAT1 antibody (L2CL4) directed against the carboxy-terminal region of human TAT1 (amino acids 664 -970) has been described elsewhere (20) . The novel antibody ; it was generated against the 50 kDa splice variant of human sAC and was previously described (39) . Horseradish peroxidase (HRP)-conjugated anti-mouse immunoglobulin and HRP-conjugated anti-rabbit immunoglobulin were purchased from Dako. Alexa 568 anti-rabbit and Alexa 594 anti-rabbit antibodies were purchased from Invitrogen. FITC anti-rabbit antibody was purchased from Dako.
Statistics
Results are expressed as mean + SEM of n observations. Sets of data were compared with a Student's t-test. Differences were considered statistically significant when P , 0.05. All statistical tests were performed using GraphPad Prism version 4.0 for Windows (Graphpad Software) and Origin version 5.0. ns, not significant; * P , 0.05, * * P , 0.01 and * * * P , 0.001.
